# A Phase 3 Comparative Study of TAP-144-SR(6M) in Postoperative and Hormone Therapy-naïve Patients With Premenopausal Breast Cancer

> **NCT01546649** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 167 (actual)

## Conditions studied

- Premenopausal Breast Cancer

## Interventions

- **DRUG:** TAP-144-SR(6M)
- **DRUG:** TAP-144-SR(3M)

## Key facts

- **NCT ID:** NCT01546649
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 167 (ACTUAL)
- **Last updated:** 2015-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01546649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01546649, "A Phase 3 Comparative Study of TAP-144-SR(6M) in Postoperative and Hormone Therapy-naïve Patients With Premenopausal Breast Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01546649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*